ANOTHER COVID-19 LIE BITES THE DUST

Hydroxychloroquine used for COVID-19 in 30,423 patients

Previously I have published a list of government misinformation, disinformation and outright lies.  See below.

List Of Lies

70.6KB ∙ PDF file

Download

Download

This list keeps expanding.  The latest addition to the list of government deceptions is that concerning the lack of safety and efficacy of hydroxychloroquine (HCQ) either alone or in combination with the antibiotic azithromycin in the treatment of COVID-19.  One may recall the heroic attempt of Mr. Clive Palmer to import tens of millions of hydroxychloroquine tablets into Australia (at his own cost) to treat COVID-19 patients at the height of the pandemic.  His attempts to save lives were blocked by the Australian government.  The shipment was seized and destroyed by the Australian Therapeutic Goods Administration (TGA) and any doctor prescribing HCQ for COVID-19 in Queensland faced gaol time.  Clive was vilified. Absolutely incredible.  This news went worldwide.  The Australian government was in full totalitarian mode and acted disgracefully.  Our “health experts” said there was no treatment for COVID-19.  People who got COVID-19 should stay at home until they either got better or got so sick they needed an ambulance to go to hospital.  At no time in history was such bad advice given for a serious infection for the elderly.

But it even got worse than that.  In order to drive people to be vaccinated with an experimental gene-therapy, clinical trials were mounted on HCQ using unapproved toxic doses in seriously ill patients who had much less chance of a successful recovery and were in the late stage of their disease just to prove that HCQ should not be used.  People died.  These trials were designed, executed and reported by doctors as part of a fear strategy to push the injections.

Now, a French retrospective analysis of the clinical records on 30,423 COVID-19 patients treated in various circumstances (outpatients, ambulatory care, or in hospital) using HCQ with azithromycin has been published.  You can read the full paper below. 

Hcq Clinical Trial 30,000

4.53MB ∙ PDF file

Download

Download

The important points from the paper were:

1.    HCQ + the antibiotic azithromycin (AZM) consistently reduced the risk of hospitalization and death

2.    If hospitalized, those pre-treated with HCQ+AZM at home had a greater chance of survival

3.    Early treatment of COVID-19 was more effective as compared to later treatment.

4.    191/23,172 patients (0.82%) treated with HCQ-AZM died, compared to 344/7,030 patients (4.89%) who did not receive HCQ-AZM.

Do you think this might be important information for a Royal Commission?  Obviously the answer is “yes”……but there will be no Royal Commission.  This will not even be discussed.  Rather, our government is focused on passing the Misinformation and Disinformation Bill 2023 to make it easier to propagate misinformation and disinformation unopposed. The senior health bureaucrats and politicians have been rewarded for their support of the false narratives and fear campaign concerning COVID vaccinations with Australian Honours, various accolades , professorships, research grants and cushy well paying jobs.

WHAT DOES DR. McCULLOUGH SAY ABOUT THIS HCQ REPORT?

“Outcomes after Early Treatment with Hydroxychloroquine and Azithromycin: An Analysis of 30,423 COVID-19 patients by Dr. Peter McCullough, Trial Site News, 6 Nov 2023.” by Peter A. McCullough, MD, MPH. CLICK HERE to view the online publication but I have also attached it below for convenience.

“We perform prospective, randomized, double-blind, placebo-controlled trials to test drugs, vaccines, devices, and other products for safety and efficacy. Randomization is important since it handles: 1) selection bias, 2) all known and unknown confounders. Despite the hundreds of billions of dollars spent during the pandemic, we did not have an investment in large, multidrug prospective, randomized, placebo controlled trials or comparative studies to test the best drug regimens.

In the end, what patients care about is how they feel, function, and survive. When it came to COVID-19, whether randomized or not, if patients survived if they were in the optimally treated group. The only way to assess how a high-risk population faired in the pandemic is to report on a large sample of patients sick with COVID-19 with a large number of the outcome of of interest—death.

Brouqui et al reported from a French database of 30,423 COVID-19 patients of whom 535 succumbed to the illness. In great detail, the investigators report mortality according to ambulatory treatment received, hospitalization, and the course over the following six weeks.

https://doi.org/10.1016/j.nmni.2023.101188

As you can see, the most favored group was those who received the regimen of hydroxychloroquine and azithromycin early in the course of illness. Of the 30,202 patients for whom treatment information was available, 191/23,172 patients (0.82%) treated with HCQ-AZM died, compared to 344/7,030 patients (4.89%) who did not receive HCQ-AZM. All the other combinations received are reported in the figure.

Important points:

1.    HCQ+AZM consistently reduced the risk of hospitalization and death

2.    If hospitalized, those pre-treated with HCQ+AZM at home had a greater chance of survival

Critics say this was not a randomized trial. Patients say it does not matter, they just want to survive on HCQ + AZM! When the differences are this large, we go with what is working for patients, not a false narrative from the Bio-Pharmaceutical Complex deceiving the population on simple, safe, generic drugs.”

MY SUBSTACK SUBSCRIPTIONS ARE ENTIRELY FREE.  I ENDEAVOUR TO BRING YOU THE TRUTH.  PLEASE SHARE WITH FRIENDS AND FAMILY.  THAT IS ALL I ASK.